Filing Details

Accession Number:
0001181431-10-026157
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-12 13:00:00
Reporting Period:
2010-05-10
Filing Date:
2010-05-12
Accepted Time:
2010-05-12 17:43:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227886 Robert Chess C/O Nektar Therapeutics
201 Industrial Road
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-10 35,000 $6.12 290,123 No 4 M Direct
Common Stock Disposition 2010-05-10 35,000 $13.95 255,123 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2010-05-10 35,000 $0.00 35,000 $6.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,004 2012-10-30 No 4 M Direct
Footnotes
  1. Transaction executed pursuant to a 10b5-1 plan adopted by the reporting person.
  2. This transaction was executed in multiple trades during the day at prices ranging from $13.57 to $14.11. The price reported above reflects the weighted-average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares subject to the stock option vested on a pro-rata monthly basis over five (5) years from the date of grant (Ocrtober 31, 2002).